Oral

[O2-1] Retrovirus2

Mon. Nov 14, 2022 4:50 PM - 6:05 PM Room 1 (Conference Room 101)

Chair:Tetsuro Matano(National Institute of Infectious Diseases), Takeshi Yoshida(National Institute of Infectious Diseases)

+Add all to schedule

4:50 PM - 5:05 PM

[O2-1-1] Analysis of HIV-1 escape mutations selected by HLA-C-restricted T cells

*Takayuki Chikata¹, Hiroyuki Gatanaga^1,2, Shinichi Oka^1,2, Masafumi Takiguchi¹ (1. Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2. AIDS Clinical Cente, National Center for Global Health and Medicine)

5:05 PM - 5:20 PM

[O2-1-2] Autologous PBMC-based vaccine to activate STLV-1-specific CTL in naturally STLV-1-infected Japanese monkeys with impaired CTL response

*Mari Kannagi^1,2, Atsuhiko Hasegawa^2,3, Megumi Murata⁴, Shinsuke Nakajima¹, Jun-ichi Fujisawa¹, Kazu Okuma¹, Hirofumi Akari⁴ (1. Kansai Medical University, 2. Tokyo Medical and Dental University, 3. Kyushu Cancer Center, 4. Kyoto University)

5:20 PM - 5:35 PM

[O2-1-3] Effects of IL-32 on HIV-1 infection

*Naofumi Takahashi¹, Hesham Nasser¹, Youseff Eltalkhawy¹, Omnia Reda¹, Sameh Lotfi¹, Jun-ichi Sakuragi², Shinya Suzu¹ (1. Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2. Division of Microbiology, Kanagawa Prefectural Institute of Public Health)

5:35 PM - 5:50 PM

[O2-1-4] DNA maintenance factor complex contributes to regulate HIV-1 latency

*Haruki Kitamura¹, Natsuki Iijima¹, Sayaka Sukegawa¹, Hiroaki Takeuchi¹ (1. Tokyo Medical and Dental University)

5:50 PM - 6:05 PM

[O2-1-5] Novel recombinant HIV model system reveals the fate of HIV activation and latency by parallel transcriptomic and epigenomic analysis

*Wajihah Binti Sakhor¹, Kenji Sugata¹, Benjy Jek Yang Tan¹, Kazuoki Monde², Chihiro Motozono³, Omnia Reda^1,4, Akhinur Rahman¹, Misaki Matsuo¹, Hitomi Nakamura⁵, Takamasa Ueno³, Yasuko Sagara⁵, Hiroaki Takeuchi⁶, Masahiro Ono⁷, Kenji Maeda^8,9, Yorifumi Satou¹ (1. Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2. Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, 3. Division of Infection and Immunity, Joint Research center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 4. Microbiology Department, High Institute of Public Health, Alexandria University, Egypt, 5. Department of Quality, Japanese Red Cross Kyushu Block Blood Center, Chikushino, Japan, 6. Department of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan, 7. Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom, 8. Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan, 9. National Center for Global Health and Medicine Research Institute, Tokyo, Japan)

Session information